Are biosimilars the same as generic cancer medicines?<\/strong><\/strong> Generics and biosimilars are different. Generics are versions of conventional medicines with the same active ingredient as the branded medicine. On the other hand, biosimilars are highly similar versions of complex biological medicines 7<\/a>,18<\/a><\/sup>.<\/p> <\/div>
Are generic cancer medicines safe?<\/strong>\u00a0<\/strong> Approved generic cancer medicines are required to meet quality and safety standards. In India, medicines supplied through Jan Aushadhi Kendras undergo batch testing at NABL-accredited laboratories before supply 19<\/a><\/sup>. However, patients should use only medicines obtained from licensed and reliable sources and should not change cancer medicines without consulting their oncologist.\u00a0<\/p> <\/div>
Where can I buy generic cancer medicines safely?<\/strong>\u00a0<\/strong><\/strong> In India, generic medicines can be purchased from licensed pharmacies and Jan Aushadhi Kendras. Jan Aushadhi Kendras are government-supported outlets that provide generic medicines at affordable prices 3<\/a>,19<\/a><\/sup>. You can check their official website to find a nearby outlet.\u00a0<\/p> <\/div>
What is the strongest medicine for cancer?<\/strong><\/strong> There is no single strongest cancer medicine. The type of medicine depends on the type and stage of cancer, cancer-related biomarkers, and the patient\u2019s individual situation 20<\/a><\/sup>. Only your oncologist can select an appropriate medicine for you.<\/p> <\/div> <\/div>\n\n\n\n
<\/span>References<\/strong><\/span><\/h2>\n\n\n\n1. Muralidharan S, Gore M, Katkuri S. Cancer care and economic burden\u2014A narrative review. J Fam Med Prim Care<\/em>. 2023;12(12):3042-3047. doi:10.4103\/jfmpc.jfmpc_1037_23. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10866236\/<\/a><\/p>\n\n\n\n
2. Leighl NB, Nirmalakumar S, Ezeife DA, Gyawali B. An Arm and a Leg: The Rising Cost of Cancer Drugs and Impact on Access. Am Soc Clin Oncol Educ Book<\/em>. 2021;(41):e1-e12. doi:10.1200\/EDBK_100028. Available from: https:\/\/www.researchgate.net\/publication\/351384786_An_Arm_and_a_Leg_The_Rising_Cost_of_Cancer_Drugs_and_Impact_on_Access<\/a>\u00a0<\/p>\n\n\n\n
3. George T, Baliga MS. Generic Anticancer Drugs of the Jan Aushadhi Scheme in India and Their Branded Counterparts: The First Cost Comparison Study. Cureus<\/em>. 13(11):e19231. doi:10.7759\/cureus.1923. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8642137\/\u00a0<\/a><\/p>\n\n\n\n
4. Joshi S, Shetty Y, Karande S. Generic drugs \u2013 The Indian scenario. J Postgrad Med<\/em>. 2019;65(2):67-69. doi:10.4103\/jpgm.JPGM_420_18. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31036775\/<\/a><\/p>\n\n\n\n
5. Behera DK, Rahut DB, Mehboobali MD, Tasneem SH, Rajendhran A. Medicine affordability and access in India: lessons from generic\u2013branded price variation under the Jan Aushadhi Scheme. Front Public Health<\/em>. 13:1629835. doi:10.3389\/fpubh.2025.1629835. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12715599\/<\/a><\/p>\n\n\n\n
6. Generic Drug Facts. FDA. Published online June 2, 2026. Accessed September 16, 2026. https:\/\/www.fda.gov\/drugs\/generic-drugs\/generic-drug-facts<\/a>\u00a0<\/p>\n\n\n\n
7. Malakar S, Gontor EN, Dugbaye MY, et al. Cancer treatment with biosimilar drugs: A review. Cancer Innov<\/em>. 2024;3(2):e115. doi:10.1002\/cai2.115. Available from: https:\/\/www.researchgate.net\/publication\/379683606_Cancer_treatment_with_biosimilar_drugs_A_review<\/a><\/p>\n\n\n\n
8. Cordeiro MA, Vitorino C, Sinogas C, Sousa JJ. A Regulatory Perspective on Biosimilar Medicines. Pharmaceutics<\/em>. 2024;16(3):321. doi:10.3390\/pharmaceutics16030321. Available from: https:\/\/www.researchgate.net\/publication\/378502770_A_Regulatory_Perspective_on_Biosimilar_Medicines<\/a><\/p>\n\n\n\n
9. Faruqui N, Martiniuk A, Sharma A, et al. Evaluating access to essential medicines for treating childhood cancers: a medicines availability, price and affordability study in New Delhi, India. BMJ Glob Health<\/em>. 2019;4(2):e001379. doi:10.1136\/bmjgh-2018-001379. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31139456\/<\/a><\/p>\n\n\n\n
10. List of new drug approvals Jan 2020 \u2013 June 2026. CDSCO. Accessed September 16, 2026. https:\/\/cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2018\/UploadBiologicalrDNA\/CT-21%20Approvals%20Jan%202020%20-%20June%202026.pdf\u00a0<\/a><\/p>\n\n\n\n
11. Reyhanoglu G, Tadi P. Etoposide. StatPearls Publishing; 2026. Accessed September 16, 2026. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557864\/\u00a0<\/a><\/p>\n\n\n\n
12. Methotrexate Sodium (Cancer Treatment). NCI. May 21, 2008. Accessed September 16, 2026. https:\/\/www.cancer.gov\/about-cancer\/treatment\/drugs\/methotrexate-sodium<\/a>\u00a0<\/p>\n\n\n\n
13. A comparative study of regulatory requirements for filing generic drug product between USA, India, and China. Accessed September 16, 2026. https:\/\/www.researchgate.net\/publication\/344758667_A_COMPARATIVE_STUDY_OF_REGULATORY_REQUIREMENTS_FOR_FILING_GENERIC_DRUG_PRODUCT_BETWEEN_USA_INDIA_AND_CHINA\u00a0<\/a><\/p>\n\n\n\n
14. Draft Guidance\u00a0 On Approval Of Clinical Trials\u00a0 & New Drugs. CDSCO. Accessed September 16, 2026. https:\/\/cdsco.gov.in\/opencms\/export\/sites\/CDSCO_WEB\/Pdf-documents\/New-Drugs\/Guidelines\/Guidance_for_New_Drug_Approval-23july2.pdf\u00a0<\/a><\/p>\n\n\n\n
15. Lopes G de L. Cost comparison and economic implications of commonly used originator and generic chemotherapy drugs in India. Ann Oncol Off J Eur Soc Med Oncol<\/em>. 2013;24 Suppl 5:v13-16. doi:10.1093\/annonc\/mdt323. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23975699\/<\/a><\/p>\n\n\n\n
16. Krishna A, Simon P, Palatty PL, et al. Cost analysis of anticancer chemotherapy and chemoirradiation regimens considering the drugs marketed through Jan Aushadhi (People\u2019s Medicine) stores and their branded counterparts: First cost comparison study. J Cancer Res Ther<\/em>. 2024;20(5):1472-1485. doi:10.4103\/jcrt.jcrt_2387_22. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39412911\/<\/a><\/p>\n\n\n\n
17. Kairi JK, Sharma AK. Substitutes of Prescription Medicines \u2013 A Review of Concerns Relevant to Doctors and Patients. J Clin Diagn Res JCDR<\/em>. 2017;11(8):FE01-FE05. doi:10.7860\/JCDR\/2017\/28552.10439. Available from: https:\/\/www.jcdr.net\/articles\/PDF\/10439\/28552_CE[Ra]F(Sh)PF1<\/em>(SY_MJ_PY)_PFA(SY_SS).pdf<\/a><\/p>\n\n\n\n
18. Biosimilars: expanding access to essential biologic therapies. WHO. Accessed September 16, 2026. https:\/\/www.who.int\/news\/item\/13-02-2025-biosimilars\u2013expanding-access-to-essential-biologic-therapies\u00a0<\/a><\/p>\n\n\n\n
19. Pradhan Mantri Bhartiya Janaushadhi Kendras. Accessed September 16, 2026. Avaiable from: https:\/\/www.pib.gov.in\/PressReleasePage.aspx?PRID=2297568&reg=48&lang=1<\/a><\/p>\n\n\n\n
20. Bashraheel SS, Domling A, Goda SK. Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine. Biomed Pharmacother<\/em>. 2020;125:110009. doi:10.1016\/j.biopha.2020.110009. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32106381\/<\/a><\/p>\n\n\n\n
Disclaimer<\/em><\/strong>: The information provided here is for educational\/awareness purposes only and is not intended to be a substitute for medical treatment by a healthcare professional and should not be relied upon to diagnose or treat any medical condition. The reader should consult a registered medical practitioner to determine the appropriateness of the information and before consuming any medication. PharmEasy does not provide any guarantee or warranty (express or\u00a0implied) regarding the accuracy, adequacy, completeness, legality, reliability or usefulness of the information; and disclaims any liability arising thereof.<\/em>\u00a0<\/p>\n\n\n\n
Links and product recommendations in the information<\/em>\u00a0provided here are advertisements of third-party products available on the website. PharmEasy does not make any representation on the accuracy or suitability of such products\/services. Advertisements do not influence the editorial decisions or content. The information in this blog is subject to change without notice. The authors and administrators reserve the right to modify, add, or remove content without notification. It is your responsibility to review this disclaimer regularly for any changes.<\/em><\/p>\n<\/body><\/html>\n
\r\n \r\n \r\n $\"Likes\"$ \r\n <\/a>\r\n <\/span>\r\n<\/div>
\r\n \r\n $\"Dislikes\"$ \r\n <\/a>\r\n <\/span>\r\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"Introduction Managing cancer can be expensive, especially when it involves long-term therapy, multiple medicines, or newer targeted and biologic treatments1,2. This can cause a significant cost burden in the lives of patients and their families.\u00a0 To help ease this burden, generic cancer medicines can offer a more affordable option (when a suitable generic is available)3. [\u2026]","protected":false},"author":203,"featured_media":291716,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_wp_rev_ctl_limit":""},"categories":[6303,10684],"tags":[14955,14953],"acf":[],"_embedded":{"wp:featuredmedia":[{"source_url":"https:\/\/pharmeasy.in\/blog\/wp-content\/uploads\/2026\/10\/genericcancer-medicines.png"}]},"_links":{"self":[{"href":"https:\/\/pharmeasy.in\/blog\/wp-json\/wp\/v2\/posts\/291669"}],"collection":[{"href":"https:\/\/pharmeasy.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmeasy.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmeasy.in\/blog\/wp-json\/wp\/v2\/users\/203"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmeasy.in\/blog\/wp-json\/wp\/v2\/comments?post=291669"}],"version-history":[{"count":7,"href":"https:\/\/pharmeasy.in\/blog\/wp-json\/wp\/v2\/posts\/291669\/revisions"}],"predecessor-version":[{"id":291746,"href":"https:\/\/pharmeasy.in\/blog\/wp-json\/wp\/v2\/posts\/291669\/revisions\/291746"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmeasy.in\/blog\/wp-json\/wp\/v2\/media\/291716"}],"wp:attachment":[{"href":"https:\/\/pharmeasy.in\/blog\/wp-json\/wp\/v2\/media?parent=291669"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmeasy.in\/blog\/wp-json\/wp\/v2\/categories?post=291669"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmeasy.in\/blog\/wp-json\/wp\/v2\/tags?post=291669"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}